Bendotti C, Samanin R
Life Sci. 1987 Aug 3;41(5):635-42. doi: 10.1016/0024-3205(87)90418-8.
8-hydroxy-2(di-n-propylamino)tetraline (8-OH-DPAT) and 5-methoxy-3(1,2,3,6-tetrahydro-4-pyridinyl)1H indole succinate (RU 24969), two agonists on the putative serotonin 1A and serotonin 1B receptors, were used for exploring the role of these sites in the inhibitory effect of serotonin (5-HT) on feeding. In free-feeding rats, 2.5-5 mg/kg RU 24969 significantly reduced food intake while doses of 8-OH-DPAT ranging from 0.125 to 0.5 mg/kg increased eating. The effects of the highest doses were associated with hyperlocomotion and hyperreactivity for RU 24969 and a typical motor syndrome (flat body posture and forepaw treading) for 8-OH-DPAT. The motor syndrome caused by 0.5 mg/kg 8-OH-DPAT was much more obvious in food-deprived rats in which food intake was also markedly reduced. RU 24969 1.25 and 5 mg/kg reduced food intake by food-deprived rats and caused hyperlocomotion not different from that in free-feeding animals. Pretreatment with metergoline (2 mg/kg i.p.) prevented the effect of 5 mg/kg RU 24969 on food intake by food-deprived rats but had no effect on the reduction of eating caused by 0.5 mg/kg 8-OH-DPAT. The motor syndrome caused by 8-OH-DPAT was not changed by metergoline but the hyperlocomotion caused by RU 24969 was potentiated. Haloperidol (0.1 mg/kg i.p.) completely blocked the hyperlocomotion but did not change the reduction of food intake caused by RU 24969 in food-deprived rats. It is suggested that the putative serotonin 1B receptors specifically mediate the inhibitory effect of 5-HT on feeding whereas serotonin 1A sites act by enhancing eating only in free-feeding animals.
8-羟基-2-(二正丙基氨基)四氢萘(8-OH-DPAT)和5-甲氧基-3-(1,2,3,6-四氢-4-吡啶基)-1H吲哚琥珀酸盐(RU 24969)是两种作用于假定的5-羟色胺1A和5-羟色胺1B受体的激动剂,被用于探究这些位点在5-羟色胺(5-HT)对摄食的抑制作用中的角色。在自由进食的大鼠中,2.5 - 5毫克/千克的RU 24969显著减少食物摄入量,而0.125至0.5毫克/千克剂量的8-OH-DPAT则增加进食量。最高剂量的效应与RU 24969引起的运动亢进和反应过度以及8-OH-DPAT引起的典型运动综合征(身体扁平姿势和前爪踩踏)有关。0.5毫克/千克的8-OH-DPAT在饥饿大鼠中引起的运动综合征更为明显,在这些大鼠中食物摄入量也显著减少。1.25和5毫克/千克的RU 24969减少了饥饿大鼠的食物摄入量,并引起了与自由进食动物无异的运动亢进。用美替拉酮(2毫克/千克,腹腔注射)预处理可防止5毫克/千克的RU 24969对饥饿大鼠食物摄入量的影响,但对0.5毫克/千克的8-OH-DPAT引起的进食减少没有影响。美替拉酮并未改变8-OH-DPAT引起的运动综合征,但增强了RU 24969引起的运动亢进。氟哌啶醇(0.1毫克/千克,腹腔注射)完全阻断了运动亢进,但并未改变饥饿大鼠中RU 24969引起的食物摄入量减少。提示假定的5-羟色胺1B受体特异性介导5-HT对摄食的抑制作用,而5-羟色胺1A位点仅在自由进食动物中通过增强进食发挥作用。